Clinical Trial: A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07652736) titled 'A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)' on June 04.

Brief Summary: The purpose of this study is to collect real-world data on treatment patterns and clinical outcomes in European patients receiving tislelizumab in routine clinical practice

Study Start Date: June 05

Study Type: OBSERVATIONAL

Condition: Advanced Non-Small Cell Lung Cancer Extensive-Stage Small Cell Lung Cancer

Intervention: DRUG: Tislelizumab

Administered as part of routine clinical practice as determined by ...